Physician profile
Walter Thomas
NPI 1154516789
$4,938.44
in general payments reported to CMS, 2019-2025
30 companies · $930 in 2025
The $930 reported for 2025 was more than what 79% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,202 · 2022: $741 · 2023: $1,082 · 2024: $983 · 2025: $930.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,996.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,995.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $704.11 | 2021-2025 | Evenity, Repatha, Otezla |
| Novo Nordisk INC | $545.88 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $443.85 | 2021-2025 | Trelegy Ellipta |
| Lilly USA, LLC | $389.85 | 2021-2025 | Mounjaro, Zepbound, Trulicity |
| Astrazeneca Pharmaceuticals Lp | $386.37 | 2021-2025 | Farxiga, Airsupra |
| Esperion Therapeutics, INC. | $312.20 | 2021-2025 | Nexletol |
| Boehringer Ingelheim Pharmaceuticals, INC. | $266.20 | 2021-2024 | Jardiance, Tradjenta |
| Janssen Pharmaceuticals, INC | $243.02 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $217.99 | 2022-2024 | |
| Pfizer INC. | $196.42 | 2021-2025 | |
| Dexcom, INC. | $181.25 | 2021-2025 | Dexcom G6 Transmitter |
| Novartis Pharmaceuticals Corporation | $161.61 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $125.17 | 2022-2025 | Verquvo, Gardasil 9, M-M-R II |
| Sanofi-Aventis U.S. LLC | $109.17 | 2021-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $93.77 | 2021-2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $82.54 | 2022-2024 | |
| Amarin Pharma, INC. | $72.83 | 2021 | |
| Hologic Sales and Service, LLC | $70.77 | 2023-2025 | Aptima, Thinprep 2000 Processor |
| Exact Sciences Corporation | $55.80 | 2023 | Cologuard Collection Kit |
| Sumitomo Pharma America, INC. | $41.30 | 2025 | Gemtesa |
| Biohaven Pharmaceuticals, INC. | $33.29 | 2021 | |
| Cranial Technologies, INC | $31.77 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $30.16 | 2023 | Eliquis, Camzyos |
| Gilead Sciences, INC. | $28.14 | 2025 | |
| Cognoa, INC. | $23.49 | 2021 | |
| Abbott Laboratories | $22.64 | 2023 | Freestyle Libre 2 |
| Biohaven Pharmaceutical Holding Company Ltd. | $20.06 | 2022 | |
| Ibsa Pharma INC. | $18.50 | 2021 | |
| Corcept Therapeutics | $15.44 | 2021 | |
| Horizon Therapeutics Plc | $14.85 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Walter Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.